By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: The Maker of First Commercial Bionic Eye Seeks Funding
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > The Maker of First Commercial Bionic Eye Seeks Funding
BusinessFinanceMedical DevicesMedical InnovationsTechnology

The Maker of First Commercial Bionic Eye Seeks Funding

Deanna Pogorelc
Deanna Pogorelc
Share
3 Min Read
SHARE

bionic eyeFirst published in MedCityNews. 

The company commercializing what’s being called the world’s first bionic eye is reloading with some fresh capital before its U.S launch.

bionic eyeFirst published in MedCityNews. 

The company commercializing what’s being called the world’s first bionic eye is reloading with some fresh capital before its U.S launch.

More Read

Administrative Costs
There’s No Business Like the Healthcare Business
Making “Best” Even Better
California Insurers Slash Number of Doctors You Can See
Health Wonk Review: September

Sylmar, California-based Second Sight Medical has its sights set on a $10.5 million round, according to a new SEC filing made this week.

Company execs couldn’t comment on details of the round but noted that they recently announced the 12 medical centers that will offer the company’s bionic eye system when it launches later this year, including Duke University Hospital, University of Michigan Kellogg Eye Center, University of Illinois Hospital and University Hospitals in Cleveland.

Second Sight’s Argus II Retinal Prosthesis System is designed to restore partial vision to people with the degenerative eye disease retinitis pigmentosa. Inspired by cochlear implants for the ear, the system comprises a retinal implant that’s surgically placed in the back of a patient’s eye, a wireless camera that’s mounted on a pair of glasses and an externally worn video processing unit. The camera captures and transmits light to the VPU, where it’s translated into “instructions” and sent back to the glasses. Then, the glasses send a wireless signal to the retinal implant, which stimulates the non-damaged cells in the retina.

While the system won’t fully restore sight, it may enable people with RP to detect light and dark in the environment and identify the location or movement of objects.

After two decades of research and development, the device got clearance from the FDA back in February under the humanitarian device exemption. Efficacy of the device has not yet been evaluated by the FDA, but the regulatory agency has deemed it safe enough to be used in clinical testing in the U.S. Argus II is already commercially available in Europe and Saudi Arabia and just launched in the Netherlands.

Company execs told MedCity News they’re also planning clinical studies to explore new indications for the device.

Originally published on MedCityNews.com.

TAGGED:bionic eyeSecond Sight Medical
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Nurse Scheduling Software
Evaluating 7 Best Nurse Scheduling Software
Nursing Technology
October 28, 2025
contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025

You Might also Like

digital-analytics-101-blogging
BusinesseHealthSocial Media

Digital Analytics 101 for Healthcare Marketers: Blogging

March 10, 2016

Britain Shows Support for Genetically Modified Embryos to Prevent Disease

July 1, 2013

Five Ways to Reduce Errors in Pathology Synoptic Reporting

October 12, 2014
New York State of health
BusinessHealth ReformPolicy & Law

Surprises in New York A.C.A. Enrollments

January 19, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?